Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.

Fabry disease is an X-linked genetic disorder caused by defects in the α-galactosidase A (GLA) gene, and heterogeneous mutations lead to quantitative and/or qualitative defects in GLA protein in male patients with Fabry disease. Random X-chromosomal inactivation modifies the clinical and biochemical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sachie Nakano, Yoshihito Morizane, Noriko Makisaka, Toshihiro Suzuki, Tadayasu Togawa, Takahiro Tsukimura, Ikuo Kawashima, Hitoshi Sakuraba, Futoshi Shibasaki
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/97d9af412dbe4f5792f909182ec9a4b7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:97d9af412dbe4f5792f909182ec9a4b7
record_format dspace
spelling oai:doaj.org-article:97d9af412dbe4f5792f909182ec9a4b72021-11-18T08:46:56ZDevelopment of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.1932-620310.1371/journal.pone.0078588https://doaj.org/article/97d9af412dbe4f5792f909182ec9a4b72013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24236025/?tool=EBIhttps://doaj.org/toc/1932-6203Fabry disease is an X-linked genetic disorder caused by defects in the α-galactosidase A (GLA) gene, and heterogeneous mutations lead to quantitative and/or qualitative defects in GLA protein in male patients with Fabry disease. Random X-chromosomal inactivation modifies the clinical and biochemical features of female patients with Fabry disease. Functional polymorphisms have been frequently reported in recent times, and these increase the difficulty of understanding the pathogenetic basis of the disease. To date, GLA protein level has been measured using an enzyme-linked immunosorbent assay (ELISA). However, ELISA is not highly sensitive due to the high background noise. In this paper, we introduce a novel application of the immuno-polymerase chain reaction (PCR) method (termed Multiple Simultaneous Tag [MUSTag]) for measurement of the GLA protein level in blood samples. We compared the sensitivities of the MUSTag method with plates or magnetic beads with those of ELISA for recombinant human GLA and found that the apparent maximal sensitivity was higher for the former than for the latter. We then measured the GLA concentrations in serum and plasma from male patients with classic Fabry disease (Male Fabry), females with Fabry disease (Female Fabry), male subjects harboring the functional polymorphism p.E66Q (E66Q), and control (Control) subjects. Our results revealed that compared to the MUSTag plate and ELISA, the MUSTag beads assay afforded a clearer estimation of the GLA protein levels in the serum and plasma with minimal or no background noise, although all the methods could differentiate between the Male Fabry, E66Q, and Control groups. The Female Fabry group showed characteristic heterogeneity, which was consistent with the X-linked inheritance. This novel method is expected to be useful for the sensitive determination of GLA level in blood and elucidation of the pathogenetic basis of Fabry disease.Sachie NakanoYoshihito MorizaneNoriko MakisakaToshihiro SuzukiTadayasu TogawaTakahiro TsukimuraIkuo KawashimaHitoshi SakurabaFutoshi ShibasakiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e78588 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sachie Nakano
Yoshihito Morizane
Noriko Makisaka
Toshihiro Suzuki
Tadayasu Togawa
Takahiro Tsukimura
Ikuo Kawashima
Hitoshi Sakuraba
Futoshi Shibasaki
Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.
description Fabry disease is an X-linked genetic disorder caused by defects in the α-galactosidase A (GLA) gene, and heterogeneous mutations lead to quantitative and/or qualitative defects in GLA protein in male patients with Fabry disease. Random X-chromosomal inactivation modifies the clinical and biochemical features of female patients with Fabry disease. Functional polymorphisms have been frequently reported in recent times, and these increase the difficulty of understanding the pathogenetic basis of the disease. To date, GLA protein level has been measured using an enzyme-linked immunosorbent assay (ELISA). However, ELISA is not highly sensitive due to the high background noise. In this paper, we introduce a novel application of the immuno-polymerase chain reaction (PCR) method (termed Multiple Simultaneous Tag [MUSTag]) for measurement of the GLA protein level in blood samples. We compared the sensitivities of the MUSTag method with plates or magnetic beads with those of ELISA for recombinant human GLA and found that the apparent maximal sensitivity was higher for the former than for the latter. We then measured the GLA concentrations in serum and plasma from male patients with classic Fabry disease (Male Fabry), females with Fabry disease (Female Fabry), male subjects harboring the functional polymorphism p.E66Q (E66Q), and control (Control) subjects. Our results revealed that compared to the MUSTag plate and ELISA, the MUSTag beads assay afforded a clearer estimation of the GLA protein levels in the serum and plasma with minimal or no background noise, although all the methods could differentiate between the Male Fabry, E66Q, and Control groups. The Female Fabry group showed characteristic heterogeneity, which was consistent with the X-linked inheritance. This novel method is expected to be useful for the sensitive determination of GLA level in blood and elucidation of the pathogenetic basis of Fabry disease.
format article
author Sachie Nakano
Yoshihito Morizane
Noriko Makisaka
Toshihiro Suzuki
Tadayasu Togawa
Takahiro Tsukimura
Ikuo Kawashima
Hitoshi Sakuraba
Futoshi Shibasaki
author_facet Sachie Nakano
Yoshihito Morizane
Noriko Makisaka
Toshihiro Suzuki
Tadayasu Togawa
Takahiro Tsukimura
Ikuo Kawashima
Hitoshi Sakuraba
Futoshi Shibasaki
author_sort Sachie Nakano
title Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.
title_short Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.
title_full Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.
title_fullStr Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.
title_full_unstemmed Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.
title_sort development of a highly sensitive immuno-pcr assay for the measurement of α-galactosidase a protein levels in serum and plasma.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/97d9af412dbe4f5792f909182ec9a4b7
work_keys_str_mv AT sachienakano developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT yoshihitomorizane developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT norikomakisaka developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT toshihirosuzuki developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT tadayasutogawa developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT takahirotsukimura developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT ikuokawashima developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT hitoshisakuraba developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
AT futoshishibasaki developmentofahighlysensitiveimmunopcrassayforthemeasurementofagalactosidaseaproteinlevelsinserumandplasma
_version_ 1718421337648660480